ES513277A0 - Un procedimiento para producir derivados de prolina. - Google Patents

Un procedimiento para producir derivados de prolina.

Info

Publication number
ES513277A0
ES513277A0 ES513277A ES513277A ES513277A0 ES 513277 A0 ES513277 A0 ES 513277A0 ES 513277 A ES513277 A ES 513277A ES 513277 A ES513277 A ES 513277A ES 513277 A0 ES513277 A0 ES 513277A0
Authority
ES
Spain
Prior art keywords
procedure
proline derivatives
producing proline
producing
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES513277A
Other languages
English (en)
Spanish (es)
Other versions
ES8307216A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP56094002A external-priority patent/JPS57209270A/ja
Priority claimed from JP56137823A external-priority patent/JPS5839661A/ja
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of ES513277A0 publication Critical patent/ES513277A0/es
Publication of ES8307216A1 publication Critical patent/ES8307216A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES513277A 1981-06-19 1982-06-18 Un procedimiento para producir derivados de prolina. Expired ES8307216A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP56094002A JPS57209270A (en) 1981-06-19 1981-06-19 Proline derivative
JP56137823A JPS5839661A (ja) 1981-09-03 1981-09-03 プロリン誘導体の製法

Publications (2)

Publication Number Publication Date
ES513277A0 true ES513277A0 (es) 1983-07-01
ES8307216A1 ES8307216A1 (es) 1983-07-01

Family

ID=26435270

Family Applications (2)

Application Number Title Priority Date Filing Date
ES513277A Expired ES8307216A1 (es) 1981-06-19 1982-06-18 Un procedimiento para producir derivados de prolina.
ES520582A Granted ES520582A0 (es) 1981-06-19 1983-03-14 Un procedimiento para producir derivados de prolina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES520582A Granted ES520582A0 (es) 1981-06-19 1983-03-14 Un procedimiento para producir derivados de prolina.

Country Status (19)

Country Link
KR (1) KR890000769B1 (ko)
AT (1) AT377496B (ko)
CA (1) CA1235120A (ko)
CH (1) CH651825A5 (ko)
DE (1) DE3222779A1 (ko)
DK (1) DK156054C (ko)
ES (2) ES8307216A1 (ko)
FI (1) FI75804C (ko)
FR (1) FR2508040B1 (ko)
GB (1) GB2102412B (ko)
HU (1) HU188177B (ko)
IL (1) IL65954A (ko)
IT (1) IT1157053B (ko)
MX (2) MX155724A (ko)
NL (1) NL193282C (ko)
NO (1) NO156408C (ko)
PT (1) PT75076B (ko)
SE (1) SE453595B (ko)
SU (1) SU1316556A3 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6354321A (ja) * 1985-03-27 1988-03-08 Ajinomoto Co Inc 血糖降下剤
KR870007114A (ko) * 1986-01-21 1987-08-14 우에노 기미오 티올 에스테르 유도체의 안정된 고형제
ZA896851B (en) 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors
DE59409631D1 (de) * 1993-07-15 2001-02-15 Hoffmann La Roche Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids

Also Published As

Publication number Publication date
FI75804C (fi) 1988-08-08
DE3222779A1 (de) 1983-01-27
DK273082A (da) 1982-12-20
NO156408B (no) 1987-06-09
IL65954A (en) 1986-03-31
CH651825A5 (de) 1985-10-15
MX171888B (es) 1993-11-23
KR840000488A (ko) 1984-02-22
NL193282B (nl) 1999-01-04
PT75076B (en) 1984-05-09
ES8307216A1 (es) 1983-07-01
FI822171A0 (fi) 1982-06-16
HU188177B (en) 1986-03-28
ES8403868A1 (es) 1984-04-01
SE453595B (sv) 1988-02-15
KR890000769B1 (ko) 1989-04-05
FR2508040A1 (fr) 1982-12-24
ES520582A0 (es) 1984-04-01
IT8267772A0 (it) 1982-06-16
NL193282C (nl) 1999-05-06
NL8202472A (nl) 1983-01-17
IT1157053B (it) 1987-02-11
IL65954A0 (en) 1982-09-30
ATA558581A (de) 1984-08-15
PT75076A (en) 1982-07-01
FI822171L (fi) 1982-12-20
DK156054C (da) 1989-11-06
FI75804B (fi) 1988-04-29
DK156054B (da) 1989-06-19
NO156408C (no) 1987-09-16
NO821997L (no) 1982-12-20
GB2102412B (en) 1985-01-09
GB2102412A (en) 1983-02-02
DE3222779C2 (ko) 1991-01-03
MX155724A (es) 1988-04-20
CA1235120A (en) 1988-04-12
SU1316556A3 (ru) 1987-06-07
SE8203814L (sv) 1982-12-20
AT377496B (de) 1985-03-25
FR2508040B1 (fr) 1986-07-04

Similar Documents

Publication Publication Date Title
ES519031A0 (es) Un procedimiento para preparar derivados de fenilciclobutano.
ES543732A0 (es) Un procedimiento para preparar derivados de aminoalquilfenaxi.
ES517732A0 (es) Un procedimiento para la preparacion de derivados de prolina.
MX156153A (es) Procedimiento para producir derivados de carboestirilo
ES553614A0 (es) Un procedimiento para preparar derivados de alanil-prolina.
ES546048A0 (es) Un procedimiento para producir derivados de propargiloxiacetonitrilo sustituido.
ES538238A0 (es) Un procedimiento para preparar derivados de adenosina.
ES513296A0 (es) Un procedimiento para preparar nuevos compuestos de cefem.
ES521047A0 (es) Un procedimiento para preparar compuestos de cefem.
ES521865A0 (es) Procedimiento de producir derivados oxazolicos.
ES530064A0 (es) Un procedimiento para la obtencion de beta-feniletanoles sustituidos.
ES555010A0 (es) Un procedimiento para preparar derivados de 3-oxobutanamido-acetato.
ES527304A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES525007A0 (es) Un procedimiento para producir derivados de tiazol
ES538036A0 (es) Un procedimiento para preparar derivados de piridona.
ES536864A0 (es) Un procedimiento para preparar derivados de azetidina sustituidos.
ES519936A0 (es) Un procedimiento para preparar derivados de pirimidona.
ES520582A0 (es) Un procedimiento para producir derivados de prolina.
ES508928A0 (es) Un procedimiento para preparar derivados de n-acil-n-hidroxi-a minoacidos.
ES506930A0 (es) Un procedimiento para preparar derivados de n-fenil-dicloro-maleimida.
ES538032A0 (es) Un procedimiento para preparar derivados de isoxazolamina.
ES513399A0 (es) Un procedimiento para preparar derivados de dialcohilpirazol
ES518123A0 (es) Un procedimiento para producir n-fosfonometilglicina.
ES520370A0 (es) Un procedimiento para obtener derivados de isoxazolopirimidina.
ES518580A0 (es) Un procedimiento para preparar un derivado de aminopropilaminobleomicina.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020401